EGFR expression and mutations can be detected using various diagnostic techniques. Immunohistochemistry (IHC) is commonly used to assess EGFR protein expression in tumor tissues. Polymerase chain reaction (PCR) and next-generation sequencing (NGS) are utilized to identify specific EGFR mutations. These diagnostic methods are essential for determining the appropriate treatment strategy.
